Biotech Values

[valueHunter]

GTCB: Does approval change short term burn?

Hey - just wondering what people's thoughts are on GTC's likely strategy going forward and the associated capital requirements? Guidance prior to approval was that current available funds will keep the juice flowing through the year. Any chance that the CHMP ruling will affect strategy in a way that will increase burn? I assume LEO is handling costs associated with market launch in Europe. Any chance they'll decide to accelerate other programs and need to raise money to do so (including accelerating the ATryn program in Japan)?

Thanks for your thoughts,
Mike.